Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 138 clinical trials
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy

Background Prostate cancer is the second leading cause of cancer death in U.S. men. Radiation is an effective treatment for most patients with localized prostate cancer, but sometimes the tumor returns. Researchers want to see if a highly focused type of radiation can help. It is given in only 5 …

recurrent prostate cancer
adenocarcinoma
ct scan
pet/ct scan
prostate tumor
  • 9 views
  • 22 Jul, 2022
  • 1 location
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cavity
measurable disease
cancer
platelet count
cancer treatment
  • 0 views
  • 30 Jun, 2022
  • 1 location
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cavity
cancer
platelet count
cancer treatment
  • 0 views
  • 30 Jun, 2022
  • 1 location
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

warfarin
measurable disease
cancer
platelet count
cancer treatment
  • 0 views
  • 25 Mar, 2022
  • 1 location
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

measurable disease
skin tumor
cancer
platelet count
cancer treatment
  • 0 views
  • 29 Jun, 2022
  • 1 location
Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination With Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vaginal Cancer

This phase I trial studies the side effects and best dose of triapine when given with radiation therapy and cisplatin in treating patients with stage IB2-IVA cervical or vaginal cancer. Triapine may stop the growth of cancer cells by blocking an enzyme needed for cell growth. Cisplatin is a drug …

absolute neutrophil count
estimated creatinine clearance
adenocarcinoma
triapine
carcinoma
  • 29 views
  • 22 Sep, 2022
  • 3 locations
Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

The purpose of this study is to assess the safety and efficacy of the Xoft Axxent eBx System when used for single-fraction IORT for recurrent Glioblastoma. IORT using the Xoft Axxent eBx System is no worse than (non-inferior) GliaSite radiation therapy when used as stand-alone radiation treatment immediately following maximal …

  • 0 views
  • 18 Mar, 2021
  • 1 location
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cancer
cancer treatment
  • 0 views
  • 05 Jul, 2022
  • 1 location
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

This phase II trial investigates whether proton radiation therapy directed to the prostate tumor, pelvic, and para-aortic lymph nodes, is an effective way to treat patients with high-risk or lymph node positive prostate cancer who are receiving radiation therapy, and if it will result in fewer gastrointestinal and genitourinary side …

  • 0 views
  • 04 Oct, 2022
  • 1 location
Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for newly Diagnosed Breast Carcinoma patients with distant metastases

erbb2
international normalized ratio
HER2
measurable disease
carcinoma
  • 0 views
  • 24 Mar, 2022
  • 1 location